KIMBERLY WARNOCK: Open Payments
NPI 1568802049 · EATONTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 16 payments from 9 companies in 2025. Trend: 2023 $570 · 2024 $827 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Dexcom, Inc. | 3 | $66 |
| Corcept Therapeutics | 2 | $47 |
| Novo Nordisk Inc | 2 | $47 |
| Esperion Therapeutics, Inc. | 1 | $29 |
| Viatris Specialty LLC | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: LEQVIO, Dexcom G6 Transmitter, Korlym, Wegovy, NEXLETOL, YUPELRI, FUROSCIX, ZEPBOUND.
Industry payments across GA — which companies pay providers there.
